FDA Inspection 1301794 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on January 22, 2026 in Lenexa, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 22, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lenexa, KS (United States)